Antifungal Strategy in Patients with Invasive Fungal Disease Associated with Hematological Malignancies Based on Risk Stratification

Table 5

Adverse reactions related to antifungal treatment in the empirical therapy and diagnostic-driven therapy groups.

Adverse reactions	Empirical therapy group	Diagnostic-driven therapy group	value
Hepatic impairment	16	18	0.59
Renal dysfunction	1	0
Visual abnormalities	11	5
Mental symptoms	5	7
Hypokalemia	12	10
Gastrointestinal symptoms	3	2